Israeli AI surgical intelligence co Theator raises $15.5m
Theator's AI-powered platform is based on smart annotation and cutting edge.
Israeli AI surgical intelligence platform company Theator today announced that it has completed a $15.5 million oversubscribed Series A financing round led by Insight Partners, with new investor Blumberg Capital, and existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Notable individual investors including 23andMe's cofounder and CEO Anne Wojcicki, former Netflix CPO Neil Hunt, and Zebra Medical Vision's cofounder Eyal Gura also participated in the round.
The round will be used by Theator to expand commercial operations and partnerships with US providers, enlarge its R&D team and consolidate its status as a leading provider of AI-powered surgical intelligence solutions to improve the performance of surgeons. Theator has raised $18.5 million to date.